RGU expects its University Entrepreneurship Accelerator to back at least 25 projects each year in areas such as healthcare, digital and social enterprise.

Lyncean, based on research at Stanford University and its SLAC National Accelerator Laboratory, has raised $13.8m in a first close of its series B round from backers such as Intel.

Stanford-StartX Fund has contributed to a $15m series B round for Fictiv, which also attracted commitments from Intel Capital and Bill Gates.

Based on research at Johns Hopkins University, Escient Pharmaceuticals is developing treatments for serious but unserved medical needs.

The Institute for Translational Medicine has been launched with $35m in funding from the National Institutes of Health to commercialise research from multiple universities.

The University of Michigan-linked vaccination technology developer has pivoted from its previous focus on antimicrobial ointments for skin infections.

Blavatnik Family Foundation has made a $15m grant to Yale University to boost its life sciences-focused fund to $25m two years after it was first established.

MIT has teamed up Socar-AQS to fund app-based technologies originating from the entrepreneurship ecosystem of Ada University.

Mike Humphrey, chairman of IP Group, will step down from his position once a replacement has been found, while Lynn Gladden will leave the firm to join a research council later this year.